RHHVF:OTCMKTS
Roche Holding AG Genussscheine
438,07Â US$
arrow_upward
+1,80%(+7,75) 1D
13 tet, 4:00:00 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për RHHVF...
Hap
434,00Â US$
I lartë
445,00Â US$
I ulët
430,00Â US$
Kapitalizimi i tregut
349,83Â mld
Vëllimi mesatar
4,73 mijë
Vëllimi
223,00
Maksimumi 52-javor
490,33Â US$
Minimumi 52-javor
318,81Â US$
Beta
0,51
Aksionet në qarkullim
702,56Â mln
Numri i punonjësve
113 mijë
Hap
434,00Â US$
I lartë
445,00Â US$
I ulët
430,00Â US$
Kapitalizimi i tregut
349,83Â mld
Vëllimi mesatar
4,73 mijë
Vëllimi
223,00
Maksimumi 52-javor
490,33Â US$
Minimumi 52-javor
318,81Â US$
Beta
0,51
Aksionet në qarkullim
702,56Â mln
Numri i punonjësve
113 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
ad-hoc-news.de
·
4 orë më parë
Hapvida signs Roche deal: target for Hapvida stock falls 10.77 percent
Reuters
·
13 orë më parë
Roche strikes obesity drug licensing deal worth up to $1.16 bln with Chinese Rona Therapeutics
Euronext Markets: Real-time Stock Market Data | live
·
13 orë më parë
Roche strikes obesity drug licensing deal worth up to $1.16 billion with Chinese Rona Therapeutics
ad-hoc-news.de
·
15 orë më parë
Roche Holding stock rises 3.44 percent on SIX
Profili
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in the Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
Rreth Roche Holding AG Genussscheine
Drejtori ekzekutivThomas Schinecker
Punonjësit113 mijë
Themeluar më1 tet 1896
SeliaBasel, Basel City, Zvicër
Sektori-
Uebsajtiroche.com